Interon Laboratories

Executive Summary

Interon Laboratories is a privately held biotechnology company headquartered in Miami, Florida, founded in 1995. The company pioneers neuro-immunotherapy, a novel category that bridges neurobiology and immunology to develop non-invasive biologics and small molecule therapeutics for neurological and immune disorders. Leveraging exclusive technology originating from MIT and Harvard Medical School, Interon aims to address significant unmet medical needs by targeting the interplay between the nervous and immune systems. While the company has not disclosed its development stage or funding, its long-standing presence since 1995 suggests sustained research efforts. As a private entity with no listed pipeline or products, Interon's progress remains opaque, but its unique scientific approach positions it as a potential innovator in the converging fields of neurology and immunology.

Upcoming Catalysts (preview)

• Q3 2026IND Filing for Lead Neuro-Immunotherapy Candidate35% success
• Q3 2026Preclinical Proof-of-Concept Data Release50% success
• TBDStrategic Partnership or Licensing Agreement40% success